iNOS-Produced Nitric Oxide from Cancer Cells as an Intermediate of Stemness Regulation by PARP-1 in Colorectal Cancer

iNOS-Produced Nitric Oxide from Cancer Cells as an Intermediate of Stemness Regulation by PARP-1 in Colorectal Cancer

PARP-1 has been linked to the progression of several types of cancer. We have recently reported that PARP-1 influences tumor progression in CRC through the regulation of CSCs in a p53-dependent manner. In this study, we propose that nitric oxide (NO) produced by inducible nitric oxide synthase (iNOS...

Full description

Saved in:

Bibliographic Details
Main Authors:	María del Moral-Martinez, Paula Sánchez-Uceta, Ruben Clemente-Gonzalez, Sara Moreno-SanJuan, Jose D. Puentes-Pardo, Huda Khaldy, David Lopez-Perez, Javier Arnedo, Jorge Casado, Luis Martínez-Heredia, Angel Carazo, Josefa León
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomolecules
Subjects:	colorectal cancer (CRC) PARP-1 iNOS cancer stem cells (CSCs)
Online Access:	https://www.mdpi.com/2218-273X/15/1/125
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects
by: Jason Sadek, et al.
Published: (2021-06-01)

The Role of Nitric Oxide in Cancer Treatment: Ally or Foe?
by: Angelika Myśliwiec, et al.
Published: (2025-06-01)

Features of iNOS activity in the skin lesions of patients with psoriasis and concomitant hypertension
by: G.І. Makurina, et al.
Published: (2016-08-01)

Nebivolol Mitigate the Hepatic Expression Level of Inducible and Endothelial Nitric Oxide Synthase in Tamoxifen-Induced Oxido-Inflammatory Changes in Female Rats
by: Noor Ahmed Hammadi, et al.
Published: (2025-06-01)

Propofol protects against high glucose-mediated endothelial injury via inhibition of COX2 and iNOS expressions
by: Shao Jiayun, et al.
Published: (2022-03-01)

Mild Hyperthermia Accelerates Bone Repair by Dynamically Regulating iNOS/Arg1 Balance in the Early Stage
by: Jinhui Zhao, et al.
Published: (2025-02-01)

DNA Methylation of iNOS, eNOS, TP53 and LINE‐1 in Gingival Tissues of Cigarette Smokers, Heat‐Not‐Burn Smokers and Never Smokers: An Exploratory Study
by: Giulio Rasperini, et al.
Published: (2025-06-01)

Curcumin mimics of potential chemoprevention with NQO1 induction properties
by: Dalia R. Aboshouk, et al.
Published: (2025-01-01)

The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
by: Derek T Hall, et al.
Published: (2018-05-01)

Upregulation of ICAM-1 Expression on J774.2 Macrophages by Endotoxin Involves Activation of NF-κB but not Protein Tyrosine Kinase: Comparison to Induction of iNOS
by: Hartmut Ruetten, et al.
Published: (1999-01-01)

A PARP inhibitors in the treatment of breast cancer - A Review of literature
by: Jagoda Niewiadomska, et al.
Published: (2024-11-01)

PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy
by: Rimvile Prokarenkaite, et al.
Published: (2025-07-01)

AQSA—Algorithm for Automatic Quantification of Spheres Derived from Cancer Cells in Microfluidic Devices
by: Ana Belén Peñaherrera-Pazmiño, et al.
Published: (2024-11-01)

PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology
by: Barbara Morone, et al.
Published: (2024-01-01)

DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment
by: Jeong Min Lee, et al.
Published: (2025-01-01)

PARP-1 as a novel target in endocrine-resistant breast cancer
by: Azzurra Zicarelli, et al.
Published: (2025-06-01)

Development of a human colorectal carcinoma cell-based platform for studying inducible nitric oxide synthase expression and nitric oxide signaling dynamics
by: Xi Chen, et al.
Published: (2025-07-01)

Etlingera Elatior Inflorescence Extract Mitigates Acute Gastric Ulcers by Suppressing the Expression of Inducible Nitric Oxide Synthase in Ethanol-Induced Wistar Rats
by: Prayoga DK, et al.
Published: (2025-06-01)

The prophylactic anti-aging effect of aspirin (acetylsalicylic acid) on oxidative stress-induced damage in the buccal mucosa of D-galactose-induced aged rats
by: Mohamed Khaled Mohamed Maria, et al.
Published: (2025-04-01)

Exploring the radiochemistry of PARP inhibitors: a new era in therapy and imaging
by: Gianluca Destro, et al.
Published: (2025-07-01)

The processed Sanguisorba officinalis L. triterpenoids prevent colon cancer through the TNF-α/NF-κB signaling pathway, combined with network pharmacology, molecular simulation dynamics and experimental verification
by: Chunli Gan, et al.
Published: (2025-06-01)

Supplementing Freezing Medium with Crocin Exerts a Protective Effect on Bovine Spermatozoa Through the Modulation of a Heat Shock-Mediated Apoptotic Pathway
by: Vasiliki Sapanidou, et al.
Published: (2025-03-01)

Specific and shared biological functions of PARP2 – is PARP2 really a lil’ brother of PARP1?
by: Magdolna Szántó, et al.
Published: (2024-01-01)

Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment
by: Luyao Wang, et al.
Published: (2025-11-01)

A case report of long-term successful use of maintenance therapy with PARP inhibitors in the primary treatment of advanced BRCA-associated ovarian cancer
by: О. N. Churuksaeva, et al.
Published: (2023-09-01)

PARP9 and PARP14 are involved in microglia-mediated neuroinflammation in Alzheimer′s disease
by: HUANG Lian, WEI Hui
Published: (2025-05-01)

Pyridazine Based Compounds with PARP-1 Inhibitory Activity
by: Norhan A. Abdelrahman, et al.
Published: (2023-12-01)

Addition of PARP1-inhibition enhances chemoradiotherapy and thermoradiotherapy when treating cervical cancer in an in vivo mouse model
by: Marloes IJff, et al.
Published: (2025-12-01)

Understanding chronic inflammation: couplings between cytokines, ROS, NO, Cai2+, HIF-1α, Nrf2 and autophagy
by: Krzysztof Piotr Michalak, et al.
Published: (2025-04-01)

STAT3 promotes IFNγ/TNFα‐induced muscle wasting in an NF‐κB‐dependent and IL‐6‐independent manner
by: Jennifer F Ma, et al.
Published: (2017-03-01)

Normalization of Cystic Fibrosis Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of Cystic Fibrosis MiceSummary
by: Callie E. Scull, et al.
Published: (2025-01-01)

Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors
by: Jiang Yu, et al.
Published: (2022-12-01)

PARP Inhibition in Colorectal Cancer—A Comparison of Potential Predictive Biomarkers for Therapy
by: Abdulaziz Alfahed
Published: (2025-06-01)

The evolving role of PARP inhibitors in advanced ovarian cancer
by: Levva Sofia, et al.
Published: (2021-08-01)

Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor
by: Bohao Jiang, et al.
Published: (2025-04-01)

PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use
by: D. S. Dolgasheva, et al.
Published: (2020-06-01)

Maprotiline inhibits COX2 and iNOS gene expression in lipopolysaccharide-stimulated U937 macrophages and carrageenan-induced paw edema in rats
by: Laleh Rafiee, et al.
Published: (2019-04-01)

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
by: Álvaro Lahiguera, et al.
Published: (2020-05-01)

TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1
by: Ming Xu, et al.
Published: (2025-01-01)

Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms
by: Jiqing Zhang, et al.
Published: (2025-04-01)